RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...I totally disagree JK, respectfully so.
Here's my two cents: I think the spinout of Zenith last year was a brilliant idea. It took the core assets and protected them from market gyrations. We have witnessed those market gyration with RVX, so it was obviously a fantastic defensive move. It also tells a buyer that if they want the crown jewels, they have to deal with the control group who are firmly in charge of that private company. Thankfully so in my view.
I suspect (personal opinion here) that the fancy new laboratory and offices are an expansion - with further expansion perhaps being anticipated. Zenith will either continue as an independent company - one that is expanding and needs a new office/laboratory to go OR is being sold off and the new office will become the low-cost, epigenetic research center in Calgary for the pharma buyer.
As for Resverlogix, I think that asset will be sold off and so the use of the office (perhaps a sublease from Zenith) could be short-term.
All of this is personal opinion. But it is my personal opinion. And it shows that the doomsday scenarios on this board about a move to a shiny new office might just be silly speculations.
Someone ought to get into their car and go see the new digs and report back here.